Lantaris

API Sourcing Trends in 2024

How Generic Companies Can Spot and Evaluate Market Opportunities for High-Barrier APIs

In the generic pharma world, most companies focus on high-volume, crowded markets. It’s a safe approach. But what about the opportunities that are often overlooked? High-barrier APIs — those with significant challenges to development or commercialization — hold unique potential for companies willing to take a calculated risk. This post explores some of the key […]

How Generic Companies Can Spot and Evaluate Market Opportunities for High-Barrier APIs Read More »

Why Qualifying Two Suppliers For Your APIs Is Essential

In contrast with Big Pharma, Generic Pharma functions on tight margins and fierce competition. For generic companies, the principle that stands out is ensuring a secure, consistent, and cost-effective supply chain, to deliver high-quality medicines which are affordable. When it comes to active pharmaceutical ingredients (APIs), the risks of relying on a single supplier are

Why Qualifying Two Suppliers For Your APIs Is Essential Read More »